Pneumococcal infection
Drug research and approvals for pneumococcal infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 28 studies of pneumococcal infection are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 28
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- A Study to Evaluate 20vPnC in Healthy Chinese InfantsNCT07754539 · Phase 3 · Pfizer · starts Jul 25, 2026
- Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and…NCT07660198 · Phase 3 · Pfizer · starts Jun 15, 2026
- A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.NCT07629440 · Phase 3 · Pfizer · starts May 29, 2026
- Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)NCT07600983 · Phase 1 / Phase 2 · CanSino Biologics Inc. · starts May 24, 2026
- A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy InfantsNCT07573462 · Phase 3 · Pfizer · starts May 4, 2026
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveNCT07358910 · Not reported · Institut Pasteur du Cambodge · starts Dec 18, 2025
- Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of AgeNCT07348692 · Phase 3 · Sanofi · starts Jan 20, 2026
- Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 YearsNCT07300644 · Phase 2 · Sinovac Life Sciences Co., Ltd. · starts Nov 25, 2025
- A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)NCT07300267 · Phase 1 · Merck Sharp & Dohme LLC · starts Jan 13, 2026
How its trials ended
254 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 94 whose ending is known, 89% met their primary endpoint, 2% missed it and 9% stopped early.
- Completed, result not reported11445%
- Met its primary endpoint8433%
- Ongoing2711%
- Status unknown197%
- Stopped: enrollment or feasibility42%
- Stopped: other or unclear42%
- Missed its primary endpoint21%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA